Phosphoinositide 3′-kinase delta: turning off BCR signaling in Chronic Lymphocytic Leukemia

por Hoellenriegel, Julia, Burger, Jan A.
Publicado 2011

PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)

por Okkenhaug, Klaus, Burger, Jan A.
Publicado 2015

Treatment algorithm for Japanese patients with chronic lymphocytic leukemia in the era of novel targeted therapies

por Kojima, Kensuke, Burger, Jan A.
Publicado 2020

Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway

por Smith, C. I. Edvard, Burger, Jan A.
Publicado 2021

Membranous nephropathy in chronic lymphocytic leukemia responsive to ibrutinib: A case report

por Turcotte, Anna-Eve, Glass, William F., Lin, Jamie S., Burger, Jan A.
Publicado 2023

Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As(2)O(3)) and all-trans retinoic acid (ATRA)

por Jain, Preetesh, Konoplev, Sergej, Benjamini, Ohad, Romagura, Jorge, Burger, Jan A.
Publicado 2018

Regulation of Mcl-1 Expression in Context to Bone Marrow Stromal Microenvironment in Chronic Lymphocytic Leukemia()

por Balakrishnan, Kumudha, Burger, Jan A., Fu, Min, Doifode, Tejaswini, Wierda, William G., Gandhi, Varsha
Publicado 2014

P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL

por Burger, Jan, Kim, Ekaterina, Sivina, Mariela, Issa, Ghayas, Thompson, Philip, G. Wierda, William, Ferrajoli, Alessandra
Publicado 2023

Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic Leukemia

por Griffen, Ti’ara L., Hoff, Fieke W., Qiu, Yihua, Burger, Jan, Wierda, William, Kornblau, Steven M.
Publicado 2023

Mesenchymal precursor cells in the blood of normal individuals

por Zvaifler, Nathan J, Marinova-Mutafchieva, Lilla, Adams, Gill, Edwards, Christopher J, Moss, Jill, Burger, Jan A, Maini, Ravinder N
Publicado 2000

P645: IBRUTINIB FOR TREATMENT OF RELAPSED-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A MATCHING-ADJUSTED INDIRECT COMPARISON OF 3 RANDOMIZED PHASE 3 TRIALS

por Ghia, Paolo, Munir, Talha, Burger, Jan, Seymour, John, Rogers, Kerry, Huang, Hsin-Hui, Moreno, Carol, Neumayr, Lynne, Abbazio, Chris, Sharman, Jeff
Publicado 2023

Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States

por Abou Dalle, Iman, Kantarjian, Hagop, Burger, Jan, Estrov, Zeev, Ohanian, Maro, Verstovsek, Srdan, Ravandi, Farhad, Borthakur, Gautam, Garcia‐Manero, Guillermo, Jabbour, Elias, Cortes, Jorge
Publicado 2019

Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia: Samples from Adults and the...

por Hoff, Fieke W., Griffen, Ti’ara L., Brown, Brandon D., Horton, Terzah M., Burger, Jan, Wierda, William, Hubner, Stefan E., Qiu, Yihua, Kornblau, Steven M.
Publicado 2023

P644: IBRUTINIB DOSE MODIFICATIONS FOR MANAGEMENT OF CARDIAC ADVERSE EVENTS IN PATIENTS WITH B-CELL MALIGNANCIES: POOLED ANALYSIS OF 10 CLINICAL TRIALS

por Stephens, Deborah, R. Brown, Jennifer, MA, Shuo, Wang, Michael, Moreno, Carol, Robak, Tadeusz, Stevens, Don, Lee, Shane, Saifan, Chadi, Hsu, Emily, Patel, Sima, Burger, Jan
Publicado 2023

Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia

por Fiorcari, Stefania, Maffei, Rossana, Audrito, Valentina, Martinelli, Silvia, Hacken, Elisa ten, Zucchini, Patrizia, Grisendi, Giulia, Potenza, Leonardo, Luppi, Mario, Burger, Jan A., Deaglio, Silvia, Marasca, Roberto
Publicado 2016

STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells

por Rozovski, Uri, Harris, David M., Li, Ping, Liu, Zhiming, Jain, Preetesh, Ferrajoli, Alessandra, Burger, Jan, Thompson, Phillip, Jain, Nitin, Wierda, William, Keating, Michael J., Estrov, Zeev
Publicado 2018

STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells

por Rozovski, Uri, Harris, David M., Li, Ping, Liu, Zhiming, Jain, Preetesh, Ferrajoli, Alessandra, Burger, Jan, Thompson, Phillip, Jain, Nitin, Wierda, William, Keating, Michael J., Estrov, Zeev
Publicado 2018

Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study

por Woyach, Jennifer A., Barr, Paul M., Kipps, Thomas J., Barrientos, Jacqueline C., Ahn, Inhye E., Ghia, Paolo, Girardi, Vincent, Hsu, Emily, Jermain, Mandy, Burger, Jan A.
Publicado 2023

Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets

por Griffen, Ti’ara L., Hoff, Fieke W., Qiu, Yihua, Lillard, James W., Ferrajoli, Alessandra, Thompson, Philip, Toro, Endurance, Ruiz, Kevin, Burger, Jan, Wierda, William, Kornblau, Steven M.
Publicado 2022

Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukemia

por Zhang, Wan, Trachootham, Dunyaporn, Liu, Jinyun, Chen, Gang, Pelicano, Helene, Garcia-Prieto, Celia, Lu, Weiqin, Burger, Jan A, Croce, Carlo M, Plunkett, William, Keating, Michael J, Huang, Peng
Publicado 2012